Literature DB >> 1613346

Squamous cell carcinoma of the nasal vestibule.

P Patel1, R Tiwari, A B Karim, J J Nauta, G B Snow.   

Abstract

We reviewed 30 patients with squamous cell carcinoma of the nasal vestibule to present our experience of their management and to evaluate the prognostic factors that may influence their outcome. For T1 lesions radiotherapy remains the treatment of choice, because of the superior cosmetic result. Fifteen (68 per cent) out of 22 patients with T2 lesions were treated with primary radiotherapy. Surgery however, was eventually required in 16 (72 per cent) out of 22 patients, either as a primary treatment (seven patients) or as salvage surgery (nine patients). For the larger T3 lesions the treatment of choice is surgery followed by post-operative radiotherapy where appropriate. Regional nodal metastases at the time of presentation were a significant indicator of local and regional recurrence and of prognosis. The cause specific five-year survival for patients with an uninvolved neck (22 patients) was 100 per cent compared with 38 per cent for patients with nodal metastases at presentation (eight patients). Elective treatment for uninvolved regional nodes is not considered necessary.

Entities:  

Mesh:

Year:  1992        PMID: 1613346     DOI: 10.1017/s0022215100119425

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  7 in total

1.  Paramedian Forehead Flap Reconstruction for a Case of Nasal Vestibular Squamous Cell Carcinoma.

Authors:  S Vijendra Shenoy; K Kshithi; Fayis Mohammed Anwar; M Panduranga Kamath
Journal:  Indian J Surg Oncol       Date:  2020-07-24

2.  Local control and intermediate-term cosmetic outcome following IMRT for nasal tumors : An update.

Authors:  Yuki Mukai; Stefan Janssen; Christoph Glanzmann; David Holzmann; Gabriela Studer
Journal:  Strahlenther Onkol       Date:  2016-12-05       Impact factor: 3.621

3.  The presence of aberrant p53 pattern is a negative prognostic predictor in squamous cell carcinoma of the nasal vestibule.

Authors:  Domenic Vital; Gerhard F Huber; David Holzmann; Holger Moch; Kristian Ikenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-01       Impact factor: 2.503

4.  Brachytherapy for primary nasal vestibule cancer using Au-198 grains.

Authors:  Hinako Harada; Yojiro Ishikawa; Shohei Tanaka; Keita Kishida; Rei Umezawa; Takaya Yamamoto; Noriyoshi Takahashi; Kazuya Takeda; Yu Suzuki; Keiichi Jingu
Journal:  Int Cancer Conf J       Date:  2022-04-08

5.  Synchronous double primary cancer of the lung and nasal vestibule: A case report and literature review.

Authors:  Huai Jun Ji; Q I Zang; Wei Wang; Ning Bo Sun; Ming Cao; Qiang Zhu; Zhong Min Jiang
Journal:  Mol Clin Oncol       Date:  2016-03-03

6.  Endonasal resection of early stage squamous cell carcinoma of the nasal vestibule.

Authors:  Georg J Ledderose; Simone Reu; Anna S Englhard; Eike Krause
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-22       Impact factor: 2.503

7.  Carbon Ion Beam Boost Irradiation in Malignant Tumors of the Nasal Vestibule and the Anterior Nasal Cavity as an Organ-Preserving Therapy.

Authors:  Fabian Eberle; Rita Engenhart-Cabillic; Markus M Schymalla; Christoph Dumke; Ulrike Schötz; Florentine S B Subtil; Kilian-Simon Baumann; Boris A Stuck; Christine Langer; Alexandra D Jensen; Henrik Hauswald; Stefan Lautenschläger
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.